Option Care Health

Q2 FY2026 EarningsQ2 FY2026 results beat consensus across the board, with revenue of $1,442.4M (vs. $1,419.0M expected) and GAAP EPS of $0.35 (vs. $0.33 expected). Adjusted EPS reached $0.45, exceeding the $0.43 mean estimate, driven by effective cost controls as SG&A expenses fell 3.8% YoY. Operating cash flow of $184M significantly outperformed expectations, while FY2026 guidance was updated with mid-point Adjusted EBITDA of $487.5M and solid sequential growth projected for Q3.